Poop pills may ease gut troubles in scleroderma patients
NCT ID NCT06333795
First seen Feb 20, 2026 · Last updated May 20, 2026 · Updated 12 times
Summary
This study tests whether a fecal microbiota transplant (FMT) can safely reduce chronic diarrhea in people with systemic sclerosis, an autoimmune disease. Twenty adults will receive either FMT or a placebo, and researchers will track side effects and symptom changes. The goal is to see if this approach is safe and offers some relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aarhus University Hospital
Aarhus, Denmark
Conditions
Explore the condition pages connected to this study.